Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO

Merck& Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.Reuters Health Information

Source: Medscape Gastroenterology Headlines - January 4, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news